<DOC>
	<DOCNO>NCT03080181</DOCNO>
	<brief_summary>Background : Pasireotide treatment strictly associate glucose metabolism impairment . The aim study evaluate effect pasireotide β -cell adipose function patient Cushing 's disease ( CD ) . Methods : Clinical hormonal parameter , insulin secretion , evaluate homostasis model assessment ( HOMA-β ) area curve ( AUC2h ) C-peptide mixed meal tolerance test insulin sensitivity , evaluate euglycemic hyperinsulinemic clamp , evaluate 12 patient active CD 12 month pasireotide . Circulating adipokines evaluate patient CD compare match group 12 diabetic patient .</brief_summary>
	<brief_title>Adipokine Profile Patients With Cushing 's Disease Pasireotide Treatment</brief_title>
	<detailed_description />
	<mesh_term>Pituitary ACTH Hypersecretion</mesh_term>
	<mesh_term>ACTH-Secreting Pituitary Adenoma</mesh_term>
	<criteria>patient active Cushing 's disease . pituitary radiotherapy treatment perform less 5 year pasireotide , pregnancy , woman take oral contraceptive , diabetes GLP1 analogue , DPP4 inhibitor sulphonylureas treatment , intolerance SSA , risk condition prolong QT syndrome severe liver renal insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>